Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuver ...

Chicago, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The global cell penetrating peptide market was valued at 2.16 billion in 2024 and is expected to reach US$ 8.12 billion by 2033, growing at a CAGR of 15.85% ...

GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary gained traction. Legend Biotech continues to invest in R&D to expand the ...

Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development Impressive Financial Growth: The group reported a 43.5% increase in revenue, ...

R&D Innovation to Lead the Future, Deepening Customer Value Creation From the performance during the 2023 reporting period, GenScript Group's overall development is optimistic, with each business ...

The peptide synthesis market is expanding due to growing demand for peptide-based therapeutics, driven by superior target specificity and lower toxicity. Innovations like microwave-assisted SPPS ...

GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering. This event will feature leading experts from academia, pharma, and biotech, showcasing the transformative ...